- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4178 - 1,3-Diazoles not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
Patent holdings for IPC class A61K 31/4178
Total number of patents in this class: 3266
10-year publication summary
273
|
241
|
256
|
237
|
225
|
273
|
239
|
207
|
205
|
120
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 4884 |
51 |
Nihon Nohyaku Co., Ltd. | 326 |
48 |
POLA Pharma Inc. | 77 |
42 |
Vicore Pharma AB | 84 |
41 |
Daiichi Sankyo Company, Limited | 1874 |
39 |
Allergan, Inc. | 2345 |
33 |
Abbvie Inc. | 1800 |
31 |
The Regents of the University of California | 19943 |
30 |
F. Hoffmann-La Roche AG | 7920 |
29 |
Achillion Pharmaceuticals, Inc. | 164 |
29 |
Gilead Sciences, Inc. | 2038 |
28 |
Theravida, Inc. | 31 |
27 |
Merck Sharp & Dohme LLC | 3742 |
27 |
Janssen Pharmaceutica N.V. | 3384 |
24 |
The Johns Hopkins University | 5671 |
23 |
Novartis AG | 10829 |
22 |
Boehringer Ingelheim International GmbH | 4644 |
21 |
Acacia Pharma Limited | 40 |
18 |
Mayo Foundation for Medical Education and Research | 3212 |
17 |
Eagle Pharmaceuticals, Inc. | 99 |
17 |
Other owners | 2669 |